Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Rosario Peluso, Francesco Caso, Marco Tasso, Vincenzo Sabbatino, Roberta Lupoli, Matteo Nicola Dario Di Minno, Francesco Ursini, Luisa Costa & Raffaele Scarpa. (2019) Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis. Open Access Rheumatology: Research and Reviews 11, pages 143-156.
Read now
Read now
Matteo Nicola Dario Di Minno, Pasquale Ambrosino, Alessandro Di Minno, Elena Tremoli & Giovanni Di Minno. (2017) The risk of gastrointestinal bleeding in patients receiving dabigatran etexilate: a systematic review and meta-analysis of the literature. Annals of Medicine 49:4, pages 329-342.
Read now
Read now
David S. H. Bell. (2016) Aspirin in the prevention of cardiovascular events in patients with diabetes. Postgraduate Medicine 128:2, pages 180-190.
Read now
Read now
Matteo Nicola Dario Di Minno, Salvatore Iervolino, Carmela Zincarelli, Roberta Lupoli, Pasquale Ambrosino, Paolo Pizzicato, Alessandro Di Minno, Nicola Pappone & Rosario Peluso. (2015) Cardiovascular effects of Etanercept in patients with psoriatic arthritis: evidence from the cardiovascular risk in rheumatic diseases database. Expert Opinion on Drug Safety 14:12, pages 1905-1913.
Read now
Read now
Giovanni Di Minno, Gaia Spadarella, Giovanni Cafaro, Maurizio Petitto, Roberta Lupoli, Alessandro Di Minno, Giovanni de Gaetano & Elena Tremoli. (2014) Systematic reviews and meta-analyses for more profitable strategies in peripheral artery disease. Annals of Medicine 46:7, pages 475-489.
Read now
Read now
Matteo Nicola Dario Di Minno, Anna Russolillo, Alessandro Di Minno, Marina Camera, Alessandro Parolari & Elena Tremoli. (2013) Direct anticoagulant drugs to overcome limitations of vitamin K antagonists. A critical appraisal of data in atrial fibrillation patients. Expert Opinion on Emerging Drugs 18:1, pages 9-23.
Read now
Read now
Articles from other publishers (23)
Hidde P. van Steenwijk, Evi Winter, Edward Knaven, Jos F. Brouwers, Myrthe van Baardwijk, Jasper B. van Dalum, Teus J. C. Luijendijk, Frits H. M. van Osch, Freddy J. Troost, Aalt Bast, Khrystyna O. Semen & Alie de Boer. (2023) The beneficial effect of sulforaphane on platelet responsiveness during caloric load: a single-intake, double-blind, placebo-controlled, crossover trial in healthy participants. Frontiers in Nutrition 10.
Crossref
Crossref
Samir K. Beura, Rishika Dhapola, Abhishek R. Panigrahi, Pooja Yadav, Reetesh Kumar, Dibbanti H. Reddy & Sunil K. Singh. (2023) Antiplatelet drugs: Potential therapeutic options for the management of neurodegenerative diseases. Medicinal Research Reviews.
Crossref
Crossref
Akhila Dandamudi, William Seibel, Benjamin Tourdot, Jose A. Cancelas, Huzoor Akbar & Yi Zheng. (2023) Structure–Activity Relationship Analysis of Rhosin, a RhoA GTPase Inhibitor, Reveals a New Class of Antiplatelet Agents. International Journal of Molecular Sciences 24:4, pages 4167.
Crossref
Crossref
Susanta Kumar Rout, Vishnu Priya, Vikas, Abhishesh Kumar Mehata & Madaswamy S. Muthu. (2022) Abciximab coated albumin nanoparticles of rutin for improved and targeted antithrombotic effect. Journal of Drug Delivery Science and Technology 76, pages 103785.
Crossref
Crossref
Jen-Fu Huang, Chi-Tung Cheng, Chih-Yuan Fu, Yu-Tung Anton Huang, Chih-Po Hsu, Chun-Hsiang OuYang, Chien-Hung Liao, Chi-Hsun Hsieh & Shang-Hung Chang. (2021) Aspirin does not increase the need for haemostatic interventions in blunt liver and spleen injuries. Injury 52:9, pages 2594-2600.
Crossref
Crossref
David S.H. Bell & Edison Goncalves. (2020) Stroke in the patient with diabetes (Part 2) – Prevention and the effects of glucose lowering therapies. Diabetes Research and Clinical Practice 164, pages 108199.
Crossref
Crossref
Akshita Rana, Erik Westein, Be'eri Niego & Christoph E. Hagemeyer. (2019) Shear-Dependent Platelet Aggregation: Mechanisms and Therapeutic Opportunities. Frontiers in Cardiovascular Medicine 6.
Crossref
Crossref
Paola Simeone, Andrea Boccatonda, Rossella Liani & Francesca Santilli. (2018) Significance of urinary 11-dehydro-thromboxane B2 in age-related diseases: Focus on atherothrombosis. Ageing Research Reviews 48, pages 51-78.
Crossref
Crossref
Urmil Pandya, Alexander Malik, Michael Messina, Abdul-Rahman Albeiruti & Chance Spalding. (2018) Reversal of antiplatelet therapy in traumatic intracranial hemorrhage: Does timing matter?. Journal of Clinical Neuroscience 50, pages 88-92.
Crossref
Crossref
Jasper Dingemanse & Andreas Krause. (2017) Impact of pharmacokinetic-pharmacodynamic modelling in early clinical drug development. European Journal of Pharmaceutical Sciences 109, pages S53-S58.
Crossref
Crossref
Hanane Khoury, Louis Lavoie, Sharon Welner & Kerstin Folkerts. (2016) The Burden of Major Adverse Cardiac Events and Antiplatelet Prevention in Patients with Coronary or Peripheral Arterial Disease. Cardiovascular Therapeutics 34:2, pages 115-124.
Crossref
Crossref
M. N. D. Di Minno, D. Esposito, A. Di Minno, G. Accardo, G. Lupoli, A. Cittadini, D. Giugliano & D. Pasquali. (2015) Increased platelet reactivity in Klinefelter men: something new to consider. Andrology 3:5, pages 876-881.
Crossref
Crossref
Alessandro Di Minno, Gaia Spadarella, Domenico Prisco, Antonella Scalera, Elena Ricciardi & Giovanni Di Minno. (2015) Antithrombotic drugs, patient characteristics, and gastrointestinal bleeding: Clinical translation and areas of research. Blood Reviews 29:5, pages 335-343.
Crossref
Crossref
Jawed Fareed, Daneyal Syed & Omer Iqbal. 2015. PanVascular Medicine. PanVascular Medicine
953
973
.
Daniela Baldoni, Shirin Bruderer, Andreas Krause, Marcello Gutierrez, Pierre Gueret, Béatrice Astruc & Jasper Dingemanse. (2014) A New Reversible and Potent P2Y12 Receptor Antagonist (ACT-246475): Tolerability, Pharmacokinetics, and Pharmacodynamics in a First-in-Man Trial. Clinical Drug Investigation 34:11, pages 807-818.
Crossref
Crossref
Peggy Tilly, Anne-Laure Charles, Sophie Ludwig, Farid Slimani, Sabrina Gross, Olivier Meilhac, Bernard Geny, Kari Stefansson, Mark E. Gurney & Jean-Etienne Fabre. (2014) Blocking the EP3 receptor for PGE2 with DG-041 decreases thrombosis without impairing haemostatic competence. Cardiovascular Research 101:3, pages 482-491.
Crossref
Crossref
Jawed Fareed, Daneyal Syed & Omer Iqbal. 2013. PanVascular Medicine. PanVascular Medicine
1
24
.
Giovanni Di Minno, Anna Russolillo, Carminio Gambacorta, Alessandro Di Minno & Domenico Prisco. (2013) Improving the use of direct oral anticoagulants in atrial fibrillation. European Journal of Internal Medicine 24:4, pages 288-294.
Crossref
Crossref
Christopher Beynon, Daniel N Hertle, Andreas W Unterberg & Oliver W Sakowitz. (2012) Clinical review: Traumatic brain injury in patients receiving antiplatelet medication. Critical Care 16:4.
Crossref
Crossref
Stephanie A. Ward, Lisa Demos, Barbara Workman & John J. McNeil. (2012) Aspirin for Primary Prevention of Cardiovascular Events in the Elderly. Drugs & Aging 29:4, pages 251-258.
Crossref
Crossref
Matteo Nicola Dario Di Minno, Roberta Lupoli, Nicola Macarone Palmieri, Anna Russolillo, Agostino Buonauro & Giovanni Di Minno. (2012) Aspirin Resistance, Platelet Turnover, and Diabetic Angiopathy: A 2011 Update. Thrombosis Research 129:3, pages 341-344.
Crossref
Crossref
MATTEO NICOLA DARIO Di MINNO, SALVATORE IERVOLINO, ROSARIO PELUSO, RAFFAELE SCARPA & GIOVANNI Di MINNO. (2012) Platelet Reactivity and Disease Activity in Subjects with Psoriatic Arthritis. The Journal of Rheumatology 39:2, pages 334-336.
Crossref
Crossref
Nicoleta Alexandru, Doina Popov & Adriana Georgescu. (2012) Platelet dysfunction in vascular pathologies and how can it be treated. Thrombosis Research 129:2, pages 116-126.
Crossref
Crossref